Cardiac resynchronization therapy: Do women benefit more than men?

Yi Zhou Xu, Paul Andrew Friedman, Tracy Webster, Kelly Brooke, David O. Hodge, Heather J. Wiste, Wei Hua, Shu Zhang, David L. Hayes, Yong-Mei Cha

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Gender and Resynchronization Therapy. Introduction: Women are underrepresented in cardiac resynchronization therapy (CRT) trials. Whether there is a gender difference in the benefit derived from CRT has not been well studied. Methods: This study included 728 consecutive CRT recipients at our institution who met guidelines for placement of a CRT device. Clinical characteristics and echocardiographic parameters were collected at baseline and after CRT; Kaplan-Meier survival analysis was performed using a national death and location database. The effects and outcome of CRT were compared between women and men. Results: Of 728 patients, 166 were female (22.8%). Female patients were younger than male patients (66.0 ± 11.9 years vs 69.4 ± 10.9 years; P < 0.001) and more often had nonischemic cardiomyopathy (68% vs 36%; P < 0.001). Both female and male patients had significantly improved clinical and echocardiographic parameters after CRT. The magnitude of improvement was similar in women and men, except that improvement in New York Heart Association (NYHA) class was greater in women than in men (-0.79 ± 0.78 vs -0.56 ± 0.85; P = 0.009). Although women were at lower risk of death than men after CRT (hazard ratio, 0.51; 95% confidence interval, 0.35-0.75; P < 0.001, unadjusted), multivariate analysis indicated gender was not, but age at CRT placement, cardiomyopathy cause, NYHA class, and lead location were independent predictors of survival. Conclusion: Female CRT recipients seem to achieve greater survival benefit than male recipients. However, this benefit is majorly driven by nonischemic cardiomyopathy and other clinical factors.

Original languageEnglish (US)
Pages (from-to)172-178
Number of pages7
JournalJournal of Cardiovascular Electrophysiology
Volume23
Issue number2
DOIs
StatePublished - Feb 2012

Fingerprint

Cardiac Resynchronization Therapy
Cardiomyopathies
Cardiac Resynchronization Therapy Devices
Survival
Kaplan-Meier Estimate
Survival Analysis
Multivariate Analysis
Databases
Guidelines
Confidence Intervals

Keywords

  • cardiac resynchronization therapy
  • cardiomyopathy
  • heart failure
  • implantable cardioverter defibrillator
  • women

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Cardiac resynchronization therapy : Do women benefit more than men? / Xu, Yi Zhou; Friedman, Paul Andrew; Webster, Tracy; Brooke, Kelly; Hodge, David O.; Wiste, Heather J.; Hua, Wei; Zhang, Shu; Hayes, David L.; Cha, Yong-Mei.

In: Journal of Cardiovascular Electrophysiology, Vol. 23, No. 2, 02.2012, p. 172-178.

Research output: Contribution to journalArticle

Xu, YZ, Friedman, PA, Webster, T, Brooke, K, Hodge, DO, Wiste, HJ, Hua, W, Zhang, S, Hayes, DL & Cha, Y-M 2012, 'Cardiac resynchronization therapy: Do women benefit more than men?', Journal of Cardiovascular Electrophysiology, vol. 23, no. 2, pp. 172-178. https://doi.org/10.1111/j.1540-8167.2011.02168.x
Xu, Yi Zhou ; Friedman, Paul Andrew ; Webster, Tracy ; Brooke, Kelly ; Hodge, David O. ; Wiste, Heather J. ; Hua, Wei ; Zhang, Shu ; Hayes, David L. ; Cha, Yong-Mei. / Cardiac resynchronization therapy : Do women benefit more than men?. In: Journal of Cardiovascular Electrophysiology. 2012 ; Vol. 23, No. 2. pp. 172-178.
@article{c37bfaca702d46e9aefc51d9df266c28,
title = "Cardiac resynchronization therapy: Do women benefit more than men?",
abstract = "Gender and Resynchronization Therapy. Introduction: Women are underrepresented in cardiac resynchronization therapy (CRT) trials. Whether there is a gender difference in the benefit derived from CRT has not been well studied. Methods: This study included 728 consecutive CRT recipients at our institution who met guidelines for placement of a CRT device. Clinical characteristics and echocardiographic parameters were collected at baseline and after CRT; Kaplan-Meier survival analysis was performed using a national death and location database. The effects and outcome of CRT were compared between women and men. Results: Of 728 patients, 166 were female (22.8{\%}). Female patients were younger than male patients (66.0 ± 11.9 years vs 69.4 ± 10.9 years; P < 0.001) and more often had nonischemic cardiomyopathy (68{\%} vs 36{\%}; P < 0.001). Both female and male patients had significantly improved clinical and echocardiographic parameters after CRT. The magnitude of improvement was similar in women and men, except that improvement in New York Heart Association (NYHA) class was greater in women than in men (-0.79 ± 0.78 vs -0.56 ± 0.85; P = 0.009). Although women were at lower risk of death than men after CRT (hazard ratio, 0.51; 95{\%} confidence interval, 0.35-0.75; P < 0.001, unadjusted), multivariate analysis indicated gender was not, but age at CRT placement, cardiomyopathy cause, NYHA class, and lead location were independent predictors of survival. Conclusion: Female CRT recipients seem to achieve greater survival benefit than male recipients. However, this benefit is majorly driven by nonischemic cardiomyopathy and other clinical factors.",
keywords = "cardiac resynchronization therapy, cardiomyopathy, heart failure, implantable cardioverter defibrillator, women",
author = "Xu, {Yi Zhou} and Friedman, {Paul Andrew} and Tracy Webster and Kelly Brooke and Hodge, {David O.} and Wiste, {Heather J.} and Wei Hua and Shu Zhang and Hayes, {David L.} and Yong-Mei Cha",
year = "2012",
month = "2",
doi = "10.1111/j.1540-8167.2011.02168.x",
language = "English (US)",
volume = "23",
pages = "172--178",
journal = "Journal of Cardiovascular Electrophysiology",
issn = "1045-3873",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Cardiac resynchronization therapy

T2 - Do women benefit more than men?

AU - Xu, Yi Zhou

AU - Friedman, Paul Andrew

AU - Webster, Tracy

AU - Brooke, Kelly

AU - Hodge, David O.

AU - Wiste, Heather J.

AU - Hua, Wei

AU - Zhang, Shu

AU - Hayes, David L.

AU - Cha, Yong-Mei

PY - 2012/2

Y1 - 2012/2

N2 - Gender and Resynchronization Therapy. Introduction: Women are underrepresented in cardiac resynchronization therapy (CRT) trials. Whether there is a gender difference in the benefit derived from CRT has not been well studied. Methods: This study included 728 consecutive CRT recipients at our institution who met guidelines for placement of a CRT device. Clinical characteristics and echocardiographic parameters were collected at baseline and after CRT; Kaplan-Meier survival analysis was performed using a national death and location database. The effects and outcome of CRT were compared between women and men. Results: Of 728 patients, 166 were female (22.8%). Female patients were younger than male patients (66.0 ± 11.9 years vs 69.4 ± 10.9 years; P < 0.001) and more often had nonischemic cardiomyopathy (68% vs 36%; P < 0.001). Both female and male patients had significantly improved clinical and echocardiographic parameters after CRT. The magnitude of improvement was similar in women and men, except that improvement in New York Heart Association (NYHA) class was greater in women than in men (-0.79 ± 0.78 vs -0.56 ± 0.85; P = 0.009). Although women were at lower risk of death than men after CRT (hazard ratio, 0.51; 95% confidence interval, 0.35-0.75; P < 0.001, unadjusted), multivariate analysis indicated gender was not, but age at CRT placement, cardiomyopathy cause, NYHA class, and lead location were independent predictors of survival. Conclusion: Female CRT recipients seem to achieve greater survival benefit than male recipients. However, this benefit is majorly driven by nonischemic cardiomyopathy and other clinical factors.

AB - Gender and Resynchronization Therapy. Introduction: Women are underrepresented in cardiac resynchronization therapy (CRT) trials. Whether there is a gender difference in the benefit derived from CRT has not been well studied. Methods: This study included 728 consecutive CRT recipients at our institution who met guidelines for placement of a CRT device. Clinical characteristics and echocardiographic parameters were collected at baseline and after CRT; Kaplan-Meier survival analysis was performed using a national death and location database. The effects and outcome of CRT were compared between women and men. Results: Of 728 patients, 166 were female (22.8%). Female patients were younger than male patients (66.0 ± 11.9 years vs 69.4 ± 10.9 years; P < 0.001) and more often had nonischemic cardiomyopathy (68% vs 36%; P < 0.001). Both female and male patients had significantly improved clinical and echocardiographic parameters after CRT. The magnitude of improvement was similar in women and men, except that improvement in New York Heart Association (NYHA) class was greater in women than in men (-0.79 ± 0.78 vs -0.56 ± 0.85; P = 0.009). Although women were at lower risk of death than men after CRT (hazard ratio, 0.51; 95% confidence interval, 0.35-0.75; P < 0.001, unadjusted), multivariate analysis indicated gender was not, but age at CRT placement, cardiomyopathy cause, NYHA class, and lead location were independent predictors of survival. Conclusion: Female CRT recipients seem to achieve greater survival benefit than male recipients. However, this benefit is majorly driven by nonischemic cardiomyopathy and other clinical factors.

KW - cardiac resynchronization therapy

KW - cardiomyopathy

KW - heart failure

KW - implantable cardioverter defibrillator

KW - women

UR - http://www.scopus.com/inward/record.url?scp=84857031074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857031074&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8167.2011.02168.x

DO - 10.1111/j.1540-8167.2011.02168.x

M3 - Article

C2 - 21914024

AN - SCOPUS:84857031074

VL - 23

SP - 172

EP - 178

JO - Journal of Cardiovascular Electrophysiology

JF - Journal of Cardiovascular Electrophysiology

SN - 1045-3873

IS - 2

ER -